Transmitted by CNW Group on : March 7, 2006 08:30

Immunotec Research Ltd. - Renowned German Anti-Aging Researcher Moves to Montreal to Join Immunotec

            MONTREAL, March 7 /CNW/ - Charles H. Roberts, President and Chief

Executive Officer of Immunotec Research Ltd., is pleased to announce the

appointment of Dr. Wulf Droege, one of the world's leading scientists in aging

research, as Senior Vice-President of Research & Development. As head of

Immunotec's R&D department, Dr. Droege will spearhead its research initiatives

in the areas of immune system optimization and anti-aging.

            Dr. Droege previously held the position of professor, Faculty of Biology,

at the University of Heidelberg and was Head of the Department of

Immunochemistry and redox physiology at Germany's National Cancer Centre in

Heidelberg (Deutsches Krebsforschungszentrum). Dr. Droege has served as the

Chairman of Immunotec's Scientific Advisory Board since 2001.

            "The whole 65-member team at our head office in Vaudreuil is delighted

that Dr. Droege has agreed to settle in the Montreal area, from his native

Germany, to take Immunotec's research activities to new levels of excellence

in the fields of aging, cancer cachexia and other disease conditions," said

Roberts.

            "To recruit such an accomplished scientist is a significant advantage for

Canada," said Roberts. "His presence among us strengthens Montreal's rapidly

expanding biotechnology cluster and its role in world markets. At Immunotec,

research is paramount."

            After many years of active research into the role of cysteine and

glutathione in cell signaling and other biological functions, Dr. Droege was

interested to extend this line of research using Immunocal/HMS 90, a natural

cysteine delivery system. His decision to move to Montreal was largely based

on his own belief that the full therapeutic potential of Immunocal / HMS 90

has not yet been fully exploited. As part of a clinical development program in

cooperation with several clinical partners, Dr. Droege will investigate

Immunocal / HMS 90's impact on: wasting processes in cancer patients, aging

and the subsequent impact on quality of life.

            Dr. Droege has published more than 250 articles in international

scientific journals. His research has been focused on the areas of redox

regulation and signaling pathways, pathogenesis of HIV infection, the

mechanisms of disease-related wasting and aging, and the action of tumor

necrosis factor.

            "We are delighted to have a researcher of Dr. Droege's experience and

accomplishments at the helm of Immunotec's R&D team, so that we can further

strengthen our research base and set new standards for health products for

today's proactive consumer," said Roberts.

            Immunotec specializes in the development of new health technologies as a

complement to traditional medicine. Combining solid science and business

practices, Immunotec delivers a line of dietary supplements, diet aids and

related products that contribute to the health, vitality and well-being of

people in twenty-two countries around the world.

            Immunotec Research Limited was co-founded in 1996 when businessmen

Roberts and Mr. Dieter Beer, a European industrialist now living in Toronto,

joined forces with researcher Dr. Gustavo Bounous, a leading expert in the

field of milk science. Immunotec is one of the industry leaders in providing

science-based nutritional supplements to the mass market. Its core products

Immunocal / HMS 90 are milk-based (whey) protein isolates, patented in Canada

and the U.S. with over twenty years of research conducted in University

teaching hospitals and medical institutions in Canada and abroad.

Immunocal / HMS 90 is the highest quality source for cysteine, and other

related ingredients, which are particularly important for the optimal function

of the immune system. Immunotec transforms the results of basic research into

real products that enhance the health and well-being of the general public.

Immunotec's investment in research sets it apart from other network marketing

companies by giving it a competitive edge and assuring that its products are

safe and effective.        

-30-

Go to product website: www.immunotec.com/dynamic